Price
No data yet.
Social Signal Score
Revenue
$34.38M+231.36%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Justin Takao
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.56
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.21
Financials
Revenue
$34.38M+231.4%Net Income
$3.36MEBITDA
$7.65MFree Cash Flow
$14.72M-43.3%EPS (diluted)
$0.08Shares Outstanding (diluted)
40.99M+97.4%Operating Expenses
$0.00Cash & Debt
$48.31MReturn of Capital
$29.92MDividend per Share
$0.12Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $35.21M | $23.29M | $0.57 |
| 2024 | $68.73M | $65.98M | $2.43 |
| 2023 | $35.84M | $53.84M | $2.26 |
| 2022 | $-56.63M | $-62.04M | $-2.99 |
| 2021 | $66.05M | $64.56M | $3.11 |
| 2020 | $17.94M | $16.18M | $0.78 |
| 2019 | $-1.95M | $-3.42M | $-0.16 |
| 2018 | $30.81M | $28.77M | $1.44 |
| 2017 | $36.80M | $35.15M | $2.30 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from KIO's reported EPS growth of -16.0% a year over 8 years. Historical EPS growth of -16% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $0.25
- Implied price
- $5.29
- Return from $11.02
- -13.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $2.63 — -76.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -25.0% | -28.8% | -26.1% | -23.8% | -21.7% | -19.9% |
| -20.0% | -24.0% | -21.2% | -18.7% | -16.5% | -14.5% |
| -15.0% | -19.3% | -16.3% | -13.6% | -11.3% | -9.2% |
| -10.0% | -14.5% | -11.3% | -8.6% | -6.1% | -3.8% |
| -5.0% | -9.8% | -6.4% | -3.5% | -0.9% | 1.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsnewsfilecorp.com·5h ago·Neutral
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation Encinitas, California--(Newsfile Corp. - August 19, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora") today announced that it has licensed the development and commercialization rights for KIO-301 in South Korea for ophthalmic indications to Chong Kun Dang Pharmaceutical Corporation (CKD). CKD, based in Seoul, is one of South Korea's l…
View source ↗
Insider trading
Open-market buys and sells by KIO officers and directors.
- Bought
- $954k
- Sold
- $248k
8 trades
5 trades
- Takao Justinsold
- Takao Justinsold
- Takao Justinsold
- Takao Justinsold
- Takao Justinsold
- Donohoe Suzannebought
- Donohoe Suzannebought
- Donohoe Suzannebought
43 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.